Drug Profile
Lazabemide
Alternative Names: Pakio; RO 196327; TempiumLatest Information Update: 24 Sep 1999
Price :
$50
*
At a glance
- Originator Roche
- Class Antiparkinsonians; Nootropics; Picolinic acids; Small molecules; Smoking cessation therapies
- Mechanism of Action Antioxidants; Monoamine oxidase B inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease; Parkinson's disease; Smoking withdrawal
Most Recent Events
- 24 Sep 1999 Discontinued-Clinical for Smoking withdrawal (PO)
- 24 Sep 1999 Discontinued-I for Parkinson's disease in New Zealand (PO)
- 24 Sep 1999 Discontinued-III for Alzheimer's disease in Europe (PO)